| 0 |
VACCINATION SITE INJURY |
1 |
0.1111 |
| 1 |
PROTEIN ALBUMIN RATIO DECREASED |
1 |
0.0455 |
| 2 |
MONKEYPOX |
3 |
0.0109 |
| 3 |
DRUG RESISTANCE MUTATION |
1 |
0.0056 |
| 4 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
1 |
0.0026 |
| 5 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 6 |
BLOOD BILIRUBIN DECREASED |
1 |
0.0016 |
| 7 |
MONOCYTOSIS |
1 |
0.0016 |
| 8 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 9 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 10 |
DRUG LEVEL FLUCTUATING |
1 |
0.0011 |
| 11 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 12 |
CD4 LYMPHOCYTES DECREASED |
2 |
0.0009 |
| 13 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 14 |
DRUG RESISTANCE |
19 |
0.0007 |
| 15 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 16 |
SLEEP PARALYSIS |
1 |
0.0007 |
| 17 |
FUNGAEMIA |
1 |
0.0006 |
| 18 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 19 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 20 |
STEATORRHOEA |
1 |
0.0004 |
| 21 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 22 |
PROCTITIS |
1 |
0.0004 |
| 23 |
DUODENAL ULCER HAEMORRHAGE |
1 |
0.0003 |
| 24 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 25 |
HEPATIC CYTOLYSIS |
3 |
0.0002 |
| 26 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 27 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 28 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 29 |
PROCTALGIA |
1 |
0.0002 |
| 30 |
SKIN LESION |
4 |
0.0001 |
| 31 |
ONYCHOCLASIS |
1 |
0.0001 |
| 32 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 33 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 34 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 35 |
OSTEOMYELITIS |
2 |
0.0001 |
| 36 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 37 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 38 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 39 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 40 |
NODULE |
1 |
0.0001 |
| 41 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 42 |
BRAIN FOG |
1 |
0.0001 |
| 43 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 44 |
URINARY RETENTION |
2 |
0.0001 |
| 45 |
EOSINOPHILIA |
1 |
0.0001 |
| 46 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 47 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 48 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 49 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 50 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 51 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 52 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 53 |
SEPTIC SHOCK |
2 |
0.0000 |
| 54 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 55 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 56 |
SKIN ULCER |
1 |
0.0000 |
| 57 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 58 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 59 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 60 |
NIGHTMARE |
1 |
0.0000 |
| 61 |
HYPERKALAEMIA |
1 |
0.0000 |
| 62 |
HYPOXIA |
1 |
0.0000 |
| 63 |
DYSURIA |
1 |
0.0000 |
| 64 |
TREATMENT FAILURE |
2 |
0.0000 |
| 65 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 66 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 67 |
HEADACHE |
14 |
0.0000 |
| 68 |
DECREASED APPETITE |
5 |
0.0000 |
| 69 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 70 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 71 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 72 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 73 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 74 |
ABDOMINAL DISCOMFORT |
3 |
0.0000 |
| 75 |
NAUSEA |
14 |
0.0000 |
| 76 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 77 |
CHILLS |
2 |
0.0000 |
| 78 |
IRRITABILITY |
1 |
0.0000 |
| 79 |
DIARRHOEA |
10 |
0.0000 |
| 80 |
FATIGUE |
12 |
0.0000 |
| 81 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 82 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 83 |
RENAL FAILURE |
2 |
0.0000 |
| 84 |
NEUTROPENIA |
2 |
0.0000 |
| 85 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 86 |
BURNING SENSATION |
1 |
0.0000 |
| 87 |
SLEEP DISORDER |
1 |
0.0000 |
| 88 |
UNDERDOSE |
1 |
0.0000 |
| 89 |
HALLUCINATION |
1 |
0.0000 |
| 90 |
PARAESTHESIA |
2 |
0.0000 |
| 91 |
DRUG INTERACTION |
2 |
0.0000 |
| 92 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 93 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 94 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 95 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 96 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 97 |
DYSPHAGIA |
1 |
0.0000 |
| 98 |
DYSPEPSIA |
1 |
0.0000 |
| 99 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 100 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 101 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 102 |
BACK PAIN |
2 |
0.0000 |
| 103 |
PALPITATIONS |
1 |
0.0000 |
| 104 |
VOMITING |
4 |
0.0000 |
| 105 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 106 |
DIZZINESS |
4 |
0.0000 |
| 107 |
PRURITUS |
3 |
0.0000 |
| 108 |
HYPERHIDROSIS |
1 |
0.0000 |
| 109 |
DRY SKIN |
1 |
0.0000 |
| 110 |
VISION BLURRED |
1 |
0.0000 |
| 111 |
HYPOAESTHESIA |
1 |
0.0000 |
| 112 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 113 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 114 |
TREMOR |
1 |
0.0000 |
| 115 |
URTICARIA |
1 |
0.0000 |
| 116 |
MYALGIA |
1 |
0.0000 |
| 117 |
OFF LABEL USE |
5 |
0.0000 |
| 118 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 119 |
SOMNOLENCE |
1 |
0.0000 |
| 120 |
CONSTIPATION |
1 |
0.0000 |
| 121 |
PAIN |
2 |
0.0000 |
| 122 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 123 |
RASH |
1 |
0.0000 |
| 124 |
DEATH |
1 |
0.0000 |